Efficacy and Safety of Vibegron Add‐On Therapy for Persistent Overactive Bladder Symptoms in Benign Prostatic Hyperplasia Patients With α 1 ‐Blocker Treatment: A Multi‐Center Prospective Randomized Controlled Study ( VATON Study)

Documenti analoghi

• Safety and Effectiveness of Vibegron in Japanese Patients With Overactive Bladder: A Japanese Postmarketing Survey
  di: Shoko Yoshimura, et al.
  Pubblicazione: (2024)
• Comparison of the 3‐Year Continuation Rate and Discontinuation Factors Between Vibegron and Mirabegron in Patients With Overactive Bladder: A Retrospective Follow‐Up Study in a Rehabilitation Hospital in Japan
  di: Shigeto Mukai, et al.
  Pubblicazione: (2024)
• Impact of Lower Urinary Tract Symptoms on Daily Life in Individuals With Co‐Existence Overactive and Underactive Bladder, Overactive Bladder, and Underactive Bladder
  di: Noritoshi Sekido, et al.
  Pubblicazione: (2025)
• Overactive Bladder Symptoms as a Predictor of Longitudinal Decline in Grip Strength in Community‐Dwelling Men: A 4‐Year Longitudinal Study
  di: Hiroyuki Sato, et al.
  Pubblicazione: (2026)
• Overactive Bladder is Positively Associated With the Prevalence and Mortality of Cancer Among US Adults
  di: Jianing Liu, et al.
  Pubblicazione: (2025)